Evidence supporting the use of: Quercetin
For the health condition: Cytomealovirus

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Quercetin is a flavonoid found in various fruits and vegetables and is recognized for its anti-inflammatory and antioxidant properties. Its use for cytomegalovirus (CMV) is supported by limited scientific evidence, largely from in vitro and some animal studies. Several laboratory studies have demonstrated that quercetin can inhibit the replication of human cytomegalovirus (HCMV) in cell culture. The proposed mechanisms include interference with viral DNA polymerase activity and downregulation of immediate early gene expression, both of which are critical for viral replication. For example, a study published in Antiviral Research (2012) found that quercetin and its derivatives could significantly reduce CMV replication in human fibroblast cells. Additionally, quercetin's general immune-modulating effects may theoretically contribute to its antiviral potential.

However, there is currently a lack of robust clinical data supporting quercetin's efficacy against CMV in humans. No large-scale clinical trials have evaluated its use for CMV infection, and available evidence is restricted to preclinical research. Therefore, while the theoretical and early experimental foundation exists, the overall quality and quantity of evidence are low. Quercetin is not considered a standard or primary therapy for CMV infection in clinical practice, and its use should not replace established antiviral medications. More research, particularly well-designed human studies, is needed to determine whether quercetin has a meaningful therapeutic role in treating or supporting patients with cytomegalovirus infection.

More about quercetin
More about Cytomealovirus

Other ingredients used for Cytomealovirus

green tea
licorice root
pomegranate
quercetin